Blue Bird Corp·4

Dec 18, 3:02 PM ET

Radulescu Razvan 4

4 · Blue Bird Corp · Filed Dec 18, 2024

Insider Transaction Report

Form 4
Period: 2024-12-17
Radulescu Razvan
Chief Financial Officer
Transactions
  • Sale

    Common Stock, par value $0.0001

    2024-12-17$42.89/sh19,171$822,24489,347 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2024-12-172,1630 total
    Exercise: $20.00From: 2024-12-11Exp: 2031-12-11Common Stock, par value $0.0001 (2,163 underlying)
  • Exercise/Conversion

    Stock Option (right to buy)

    2024-12-173,5043,503 total
    Exercise: $12.35Exp: 2032-12-12Common Stock, par value $0.0001 (3,504 underlying)
  • Exercise/Conversion

    Stock Option (right to buy)

    2024-12-173,5040 total
    Exercise: $12.35From: 2024-12-12Exp: 2032-12-12Common Stock, par value $0.0001 (3,504 underlying)
  • Exercise/Conversion

    Common Stock, par value $0.0001

    2024-12-17$20.00/sh+2,163$43,260101,510 total
  • Exercise/Conversion

    Common Stock, par value $0.0001

    2024-12-17$12.35/sh+3,504$43,274108,518 total
  • Exercise/Conversion

    Common Stock, par value $0.0001

    2024-12-17$12.35/sh+3,504$43,274105,014 total
Footnotes (2)
  • [F1]The price reported in Column 4 is a weighted average price resulting from shares sold in multiple transactions on December 17, 2024, pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 12, 2024, at prices ranging from $42.60 to $43.58, inclusive. The reporting person undertakes to provide to Blue Bird Corporation, any security holder of Blue Bird Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  • [F2]One of the option's three tranches vested on December 12, 2024.

Documents

1 file
  • 4
    wk-form4_1734552169.xmlPrimary

    FORM 4